Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey

International Journal of Clinical Practice

Volumn 60, Issue 10, 2006, Pages 1166-1171

  Farnier, Michel ^a   Garnier, P ^b   Yau, C ^c   Dejager, S ^c   Verpilleux, M P ^c  

^a Rond Point de la Nation ^*  (France)

^b Pouilly en Auxois   (France)

^c Laboratoires Novartis France   (France)

Author keywords

Cardiovascular disease; Cholesterol; High density lipoprotein; Obesity; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRANCE; HEALTH PROGRAM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS;

EID: 33748559051     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01124.x     Document Type: Article

References (22)

1. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 1992; 70: 733-7.
2. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997; 17: 1114-20.
3. Gotto AM Jr. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Am Heart J 2002; 144: S33-42.
4. Gotto AM Jr. Low high density lipoprotein as a risk factor in coronary heart disease. Circulation 2001; 103: 2213-8.
5. Gordon DJ, Probstfield JL, Garrison RJ et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15.
6. Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 1997; 95: 1-4.
7. Reaven GM. Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 1988; 12: 1595-607.
8. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005; 48: 1684-99.
9. Balkau B, Vernay M, Mhamdi L et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab 2003; 29: 526-32.
10. Balkau B, Charles MA, Drivsholm T et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364-76.
11. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
12. Bruckert E, Baccara-Dinet M, McCoy F, Chapman J. High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients. Curr Med Res Opin 2005; 21: 1927-34.
13. Grundy SM, Cleeman JI, Bairey Merz CN et al. Implications of recent clinical trials for the National Cholesterol Educations Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-39.
14. Sacks FM, Expert Group on HDL Cholesterol. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: Expert group recommendations. Am J Cardiol 2002; 90: 139-43.
15. Tverdal A. Calculation of risk for the development of acute myocardial infarction in the normal population based on long-term follow-up studies: Smokers compared with non-smokers. J Cardiovasc Risk 1999; 6: 287-91.
16. Phillips NR, Havel RJ, Kane JP. Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides. Association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine. Arteriosclerosis 1981; 1: 13-24.
17. Ernst N, Fisher M, Smith W et al. The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. The Lipid Research Clinics Prevalence Study. Circulation 1980; 62: 41-52.
18. Couillard C, Despres JP, Lamarche B et al. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: Evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 2001; 21: 1226-32.
19. Williams PT. High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. N Engl J Med 1996; 334: 1298-303.
20. Chan DC, Barrett HPR, Watts GF. Dyslipidemia in visceral obesity. Mechanisms, implications, and therapy. Am J Cardiovasc Drugs 2004; 4: 227-46.
21. Yamamoto A, Temba H, Horibe H et al. Life style and cardiovascular risk factors in the Japanese population - from an epidemiological survey on serum lipid levels in Japan 1990 part 1: Influence of life style and excess body weight on HDL-cholesterol and other lipid parameters in men. J Atheroscler Thromb 2003; 10: 165-75.
22. Lemieux I, Pascot A, Couillard C et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-84.